Welcome to the New Mexico Chapter of the American College of Cardiology
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Please join your cardiology colleagues at the ACC Rockies Chapter Meeting in Park City, Utah for updates on ACC affairs, the potential new CV Board, and clinical topics such as Genetic and Sports EP, plus a discussion on the growing role of obesity medications in heart failure, and the first-ever Cardiology State-of-the-State report. There will be many opportunities for networking, as well!.
For more information and to register, please visit: 
Latest in Cardiology from ACC.org
- State-of-the-Art Review Outlines Multidisciplinary Framework For Cardiogenic Shock SurvivorshipWith survival rates after cardiogenic shock (CS) increasing, a JACC State-of-the-Art Review outlines a multidisciplinary, longitudinal approach to CS care aimed at "providing a clinically actionable structure for care pathways, resource planning and future research."
- Joint Clinical Consensus Statement Focuses on Masters Athletes With Abnormal CV FindingsMasters athletes, defined as adults over the age of 35 years, with more than 300 minutes per week of exercise training, are driven by performance goals in addition to health goals. For those with abnormal CV findings, diagnostic assessment, treatment options, and exercise prescriptions or restrictions have limited generalizability...
- JACC Spotlight Issue Highlights New 2026 Acute PE GuidelineA new Spotlight Issue of JACC centers on the Guideline For the Evaluation and Management of Acute Pulmonary Embolism in Adults, released by the ACC and AHA earlier this year.
- Eagle’s Eye View: Top Takeaways from ACC.26In this week’s View, Dr. Eagle highlights trials from the recently held ACC Scientific Sessions which took place in New Orleans, March 28-30.
- HOST-EXAM: Clopidogrel vs. Aspirin Monotherapy at 10 Years Post PCIClopidogrel monotherapy after PCI was associated with a significantly lower composite risk of all-cause death, nonfatal MI, stroke, readmission for acute coronary syndrome (ACS) and major bleeding compared with aspirin monotherapy, according to 10-year follow-up results of the HOST-EXAM trial presented as featured clinical research at ACC.26 and published simultaneously in The Lancet.